yqyqynesara.blogspot.com
The money was granted in collaborationj withthe U.S. Army Medical Researcj and Materiel Command and the throughthe Ft. Detric k Technology Transfer Initiative. The purpose of the technology transferr program is to raise awareness of new and developing technologies and funding them to transitiom as viable projectsfor follow-on fundinvg in the market place. Each company that receivedd funding was awardedapproximately $50,000 betweenn March 2008 and May 2009, makinfg up the initiative’s second round of financial awards sinc e its $750,000 program extension. The funds for the program’x second phase were secured by Sen. Barbarwa Mikulski, D-Md., and Rep. Roscoe G. Bartlett, R-Md.
“Thd [Ft. Detrick Technology Transfer Initiative] prograjm is enabling area businesses to harness the technologies being developed at Fort Detrick and applu them to thecommercial sector,” said Mikulski. “This will lead to new productes that have the power to create jobs andsave lives.” Mikulski announced the firsrt phase of the tech transfer program in Marchu 2005 when 11 companies received funding. in Rockville: The companyg is developing a health care technology calledmiTagf system, which is a scalabld wireless sensor solution for improvingt patient flow.
in Frederick: The company is developingb a technology called the GeNova Screento identify, isolate, and producde antibody-like molecules. in Rockville: The companyu is developing an on-demand biotech products including a combination vaccine against plagueand anthrax. BioAssag Works LLC in Ijamsville: The company is developing a lateral-flos visual diagnostic test to detect and differentiate single sample multiplepathogenic poxviruses, includingy variola, vaccinia, and in Catonsville: The company is safety-testinv a medical product called ClotFoam, which is a intracavitary hemostatic agent.
CynerGene IDMP in Frederick: The companty is developing, validating and implementing a supplemental diagnosisof Malaria, HIV, and Dengue using its Infectiouas Disease Multiplex Panel approach, whic h could allow for creation of biosensors. LLC in The company is developint required components and system framework to enable conversationa interfaces for telemedicine Such tools would allow professiona l medics touse voice, and other human-- computer interactions to access and documenr information in electronic medical records.
in Rockville: The compant is developing technology to preserve mammalian cells in dried format that can easilybe re-hydrated for a variety of LLC in Frederick: The company is evaluating the effec t of Imagilin patented probiotics as a food supplementf to enhance the immune responsiveness of guinea pigs upon immunizatiomn or challenge with virulent pathogens. The evaluation will suggestt the ability of Imagilin patented probiotics to enhanc the immunization ofa vaccine. in The company is developing micropatterned substrates for viralinfectivitty assays. Juxtopia in Baltimore: The company is customizing its Wearable Assistance and SituationaplAwareness (WASA) goggles and service to allow U.
S. Army combay medics to access and document informationh to electrical medical recordsvia hands-free voice-requests and in Baltimore: The company is developing cell therapies to treat brain and spinal cord
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment